Is SHC or FTRE more profitable?

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% Fortrea -16.50% 9.51% 1.96%

Does the media refer more to SHC or FTRE?

In the previous week, Fortrea had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Fortrea and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat Fortrea's score of 0.93 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CAI or FTRE?

In the previous week, Caris Life Sciences had 1 more articles in the media than Fortrea. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Caris Life Sciences' score of 0.33 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, FTRE or RDNT?

RadNet has lower revenue, but higher earnings than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fortrea $2.72B 0.53 -$986.20M -$4.91 N/A RadNet $2.14B 1.91 -$18.65M -$0.18 N/A

Is FTRE or RDNT more profitable?

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets Fortrea -16.50% 9.51% 1.96% RadNet -0.66% 2.77% 0.97%

Does the media refer more to FTRE or RDNT?

In the previous week, RadNet had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat RadNet's score of 0.30 indicating that Fortrea is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, FTRE or BLLN?

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fortrea $2.72B 0.53 -$986.20M -$4.91 N/A Billiontoone $305.11M 14.88 $7.45M $0.55 179.45

Does the media favor FTRE or BLLN?

In the previous week, Billiontoone had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Fortrea. Billiontoone's average media sentiment score of 1.09 beat Fortrea's score of 0.93 indicating that Billiontoone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, VCYT or FTRE?

Veracyte has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $517.15M 7.37 $66.35M $1.09 43.84 Fortrea $2.72B 0.53 -$986.20M -$4.91 N/A

Is VCYT or FTRE more profitable?

Veracyte has a net margin of 16.25% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Veracyte's return on equity. Company Net Margins Return on Equity Return on Assets Veracyte 16.25% 9.07% 8.38% Fortrea -16.50% 9.51% 1.96%

Does the media prefer VCYT or FTRE?

In the previous week, Veracyte had 13 more articles in the media than Fortrea. MarketBeat recorded 16 mentions for Veracyte and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Veracyte's score of 0.36 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Fortrea (FTRE) Competitors

$15.40 +0.04 (+0.26%)

As of 12:26 PM Eastern

Compare

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include Sotera Health (SHC), Caris Life Sciences (CAI), RadNet (RDNT), Billiontoone (BLLN), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Fortrea compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Fortrea	-16.50%	9.51%	1.96%

Sotera Health has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, meaning that its share price is 112% more volatile than the broader market.

In the previous week, Fortrea had 1 more articles in the media than Sotera Health. MarketBeat recorded 3 mentions for Fortrea and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.15 beat Fortrea's score of 0.93 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.69	$77.94M	$0.41	36.73
Fortrea	$2.72B	0.53	-$986.20M	-$4.91	N/A

Sotera Health currently has a consensus price target of $20.33, indicating a potential upside of 35.02%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 12.23%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Summary

Sotera Health beats Fortrea on 13 of the 16 factors compared between the two stocks.

How does Fortrea compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

Caris Life Sciences presently has a consensus price target of $27.56, indicating a potential upside of 75.18%. Fortrea has a consensus price target of $17.25, indicating a potential upside of 12.23%. Given Caris Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Caris Life Sciences has a net margin of 3.75% compared to Fortrea's net margin of -16.50%. Caris Life Sciences' return on equity of 98.28% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Fortrea	-16.50%	9.51%	1.96%

Caris Life Sciences has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	5.48	-$68.09M	-$7.61	N/A
Fortrea	$2.72B	0.53	-$986.20M	-$4.91	N/A

In the previous week, Caris Life Sciences had 1 more articles in the media than Fortrea. MarketBeat recorded 4 mentions for Caris Life Sciences and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Caris Life Sciences' score of 0.33 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Caris Life Sciences beats Fortrea on 10 of the 13 factors compared between the two stocks.

How does Fortrea compare to RadNet?

Fortrea (NASDAQ:FTRE) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

RadNet has lower revenue, but higher earnings than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.53	-$986.20M	-$4.91	N/A
RadNet	$2.14B	1.91	-$18.65M	-$0.18	N/A

Fortrea currently has a consensus price target of $17.25, suggesting a potential upside of 12.23%. RadNet has a consensus price target of $87.43, suggesting a potential upside of 67.58%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
RadNet	-0.66%	2.77%	0.97%

In the previous week, RadNet had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for RadNet and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat RadNet's score of 0.30 indicating that Fortrea is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fortrea has a beta of 2.12, suggesting that its stock price is 112% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

77.9% of RadNet shares are owned by institutional investors. 0.7% of Fortrea shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

RadNet beats Fortrea on 11 of the 17 factors compared between the two stocks.

How does Fortrea compare to Billiontoone?

Fortrea (NASDAQ:FTRE) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

In the previous week, Billiontoone had 2 more articles in the media than Fortrea. MarketBeat recorded 5 mentions for Billiontoone and 3 mentions for Fortrea. Billiontoone's average media sentiment score of 1.09 beat Fortrea's score of 0.93 indicating that Billiontoone is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.53	-$986.20M	-$4.91	N/A
Billiontoone	$305.11M	14.88	$7.45M	$0.55	179.45

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Billiontoone	N/A	N/A	N/A

Fortrea presently has a consensus target price of $17.25, indicating a potential upside of 12.23%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 26.94%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts clearly believe Billiontoone is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Billiontoone beats Fortrea on 10 of the 13 factors compared between the two stocks.

How does Fortrea compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Veracyte currently has a consensus target price of $47.57, suggesting a potential downside of 0.46%. Fortrea has a consensus target price of $17.25, suggesting a potential upside of 12.23%. Given Fortrea's higher possible upside, analysts clearly believe Fortrea is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Fortrea	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.36

Veracyte has a beta of 1.98, meaning that its stock price is 98% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.12, meaning that its stock price is 112% more volatile than the broader market.

In the previous week, Veracyte had 13 more articles in the media than Fortrea. MarketBeat recorded 16 mentions for Veracyte and 3 mentions for Fortrea. Fortrea's average media sentiment score of 0.93 beat Veracyte's score of 0.36 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Fortrea	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	7.37	$66.35M	$1.09	43.84
Fortrea	$2.72B	0.53	-$986.20M	-$4.91	N/A

Veracyte has a net margin of 16.25% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Fortrea	-16.50%	9.51%	1.96%

Summary

Veracyte beats Fortrea on 9 of the 15 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.45B	$3.26B	$6.26B	$12.44B
Dividend Yield	N/A	2.33%	2.69%	5.30%
P/E Ratio	-3.13	17.75	22.35	24.23
Price / Sales	0.53	323.71	555.60	126.08
Price / Cash	1.59	116.27	42.31	57.88
Price / Book	2.52	6.55	9.82	6.73
Net Income	-$986.20M	$24.20M	$3.56B	$336.97M
7 Day Performance	14.53%	-3.25%	-1.16%	0.79%
1 Month Performance	26.19%	0.48%	3.85%	5.38%
1 Year Performance	231.97%	47.06%	27.33%	34.55%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	3.8979 of 5 stars	$15.40 +0.3%	$17.25 +12.0%	+271.9%	$1.46B	$2.72B	N/A	14,300
SHC Sotera Health	3.7812 of 5 stars	$15.66 flat	$20.33 +29.8%	+23.2%	$4.47B	$1.16B	38.20	3,000
CAI Caris Life Sciences	4.7627 of 5 stars	$15.55 flat	$27.56 +77.2%	N/A	$4.40B	$812.03M	N/A	1,846	Analyst Downgrade
RDNT RadNet	3.7995 of 5 stars	$54.40 flat	$87.43 +60.7%	-6.8%	$4.28B	$2.04B	N/A	11,264
BLLN Billiontoone	4.809 of 5 stars	$85.92 flat	$125.29 +45.8%	N/A	$3.95B	$305.11M	156.22	620	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Fortrea compare to Sotera Health?

Summary

How does Fortrea compare to Caris Life Sciences?

Summary

How does Fortrea compare to RadNet?

Summary

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. SHC, CAI, RDNT, BLLN, and VCYT

How does Fortrea compare to Sotera Health?

Do insiders & institutionals hold more shares of SHC or FTRE?

Is SHC or FTRE more profitable?

Which has more volatility and risk, SHC or FTRE?

Does the media refer more to SHC or FTRE?

Which has stronger valuation and earnings, SHC or FTRE?

Do analysts prefer SHC or FTRE?

Summary

How does Fortrea compare to Caris Life Sciences?

Do analysts rate CAI or FTRE?

Is CAI or FTRE more profitable?

Which has stronger valuation & earnings, CAI or FTRE?

Does the media favor CAI or FTRE?

Summary

How does Fortrea compare to RadNet?

Which has higher valuation & earnings, FTRE or RDNT?

Do analysts recommend FTRE or RDNT?

Is FTRE or RDNT more profitable?

Does the media refer more to FTRE or RDNT?

Which has more volatility & risk, FTRE or RDNT?

Do insiders & institutionals hold more shares of FTRE or RDNT?

Summary

How does Fortrea compare to Billiontoone?

Does the media favor FTRE or BLLN?

Which has preferable earnings & valuation, FTRE or BLLN?

Is FTRE or BLLN more profitable?

Do analysts recommend FTRE or BLLN?

Summary

How does Fortrea compare to Veracyte?

Do analysts rate VCYT or FTRE?

Which has more risk and volatility, VCYT or FTRE?

Does the media prefer VCYT or FTRE?

Which has stronger valuation & earnings, VCYT or FTRE?

Is VCYT or FTRE more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools